nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—PTGS2—colon cancer	0.216	0.54	CbGaD
Acetaminophen—ABCB1—colon cancer	0.184	0.46	CbGaD
Acetaminophen—UGT1A9—Irinotecan—colon cancer	0.091	0.257	CbGbCtD
Acetaminophen—UGT1A1—Irinotecan—colon cancer	0.0744	0.21	CbGbCtD
Acetaminophen—CYP2A6—Fluorouracil—colon cancer	0.0424	0.12	CbGbCtD
Acetaminophen—CYP2C9—Capecitabine—colon cancer	0.0246	0.0696	CbGbCtD
Acetaminophen—CYP2C8—Fluorouracil—colon cancer	0.0209	0.0592	CbGbCtD
Acetaminophen—SLC22A6—Methotrexate—colon cancer	0.0175	0.0496	CbGbCtD
Acetaminophen—CYP1A2—Fluorouracil—colon cancer	0.0162	0.0458	CbGbCtD
Acetaminophen—ABCB1—Irinotecan—colon cancer	0.0148	0.0417	CbGbCtD
Acetaminophen—CYP2C9—Fluorouracil—colon cancer	0.0146	0.0413	CbGbCtD
Acetaminophen—ABCB1—Vincristine—colon cancer	0.0129	0.0365	CbGbCtD
Acetaminophen—CYP3A4—Irinotecan—colon cancer	0.00884	0.025	CbGbCtD
Acetaminophen—ABCB1—Methotrexate—colon cancer	0.00781	0.0221	CbGbCtD
Acetaminophen—CYP3A4—Vincristine—colon cancer	0.00773	0.0218	CbGbCtD
Acetaminophen—UGT2B15—gall bladder—colon cancer	0.0039	0.0538	CbGeAlD
Acetaminophen—UGT1A10—renal system—colon cancer	0.00283	0.039	CbGeAlD
Acetaminophen—NAT2—renal system—colon cancer	0.00263	0.0362	CbGeAlD
Acetaminophen—UGT1A10—digestive system—colon cancer	0.00232	0.032	CbGeAlD
Acetaminophen—UGT1A6—digestive system—colon cancer	0.00216	0.0297	CbGeAlD
Acetaminophen—SULT2A1—digestive system—colon cancer	0.002	0.0276	CbGeAlD
Acetaminophen—SULT1A1—renal system—colon cancer	0.00194	0.0268	CbGeAlD
Acetaminophen—SULT1E1—lymphoid tissue—colon cancer	0.00187	0.0258	CbGeAlD
Acetaminophen—SULT1E1—digestive system—colon cancer	0.00185	0.0255	CbGeAlD
Acetaminophen—TRPV1—epithelium—colon cancer	0.00184	0.0254	CbGeAlD
Acetaminophen—UGT1A10—liver—colon cancer	0.00173	0.0238	CbGeAlD
Acetaminophen—TRPV1—renal system—colon cancer	0.00171	0.0236	CbGeAlD
Acetaminophen—SULT1E1—vagina—colon cancer	0.00163	0.0225	CbGeAlD
Acetaminophen—NAT2—liver—colon cancer	0.00161	0.0221	CbGeAlD
Acetaminophen—UGT1A6—liver—colon cancer	0.00161	0.0221	CbGeAlD
Acetaminophen—SULT1A1—digestive system—colon cancer	0.00159	0.022	CbGeAlD
Acetaminophen—UGT2B15—digestive system—colon cancer	0.00154	0.0212	CbGeAlD
Acetaminophen—SULT2A1—liver—colon cancer	0.00149	0.0206	CbGeAlD
Acetaminophen—UGT1A9—renal system—colon cancer	0.00142	0.0196	CbGeAlD
Acetaminophen—SULT1A1—vagina—colon cancer	0.00141	0.0194	CbGeAlD
Acetaminophen—TRPV1—digestive system—colon cancer	0.0014	0.0193	CbGeAlD
Acetaminophen—SULT1E1—liver—colon cancer	0.00138	0.019	CbGeAlD
Acetaminophen—SULT1A1—liver—colon cancer	0.00119	0.0164	CbGeAlD
Acetaminophen—UGT1A9—digestive system—colon cancer	0.00116	0.0161	CbGeAlD
Acetaminophen—SULT2A1—lymph node—colon cancer	0.00114	0.0158	CbGeAlD
Acetaminophen—UGT2B15—liver—colon cancer	0.00114	0.0158	CbGeAlD
Acetaminophen—SULT1E1—lymph node—colon cancer	0.00106	0.0146	CbGeAlD
Acetaminophen—CNR1—lymph node—colon cancer	0.000988	0.0136	CbGeAlD
Acetaminophen—UGT1A1—renal system—colon cancer	0.000973	0.0134	CbGeAlD
Acetaminophen—SULT1A1—lymph node—colon cancer	0.000909	0.0125	CbGeAlD
Acetaminophen—PTGS1—endothelium—colon cancer	0.000896	0.0124	CbGeAlD
Acetaminophen—UGT1A9—liver—colon cancer	0.000867	0.012	CbGeAlD
Acetaminophen—PTGS2—endothelium—colon cancer	0.000857	0.0118	CbGeAlD
Acetaminophen—PTGS1—blood vessel—colon cancer	0.000827	0.0114	CbGeAlD
Acetaminophen—UGT1A1—digestive system—colon cancer	0.000798	0.011	CbGeAlD
Acetaminophen—PTGS2—blood vessel—colon cancer	0.00079	0.0109	CbGeAlD
Acetaminophen—PTGS2—gall bladder—colon cancer	0.000744	0.0103	CbGeAlD
Acetaminophen—UGT1A1—liver—colon cancer	0.000594	0.0082	CbGeAlD
Acetaminophen—CYP2A6—vagina—colon cancer	0.000594	0.00819	CbGeAlD
Acetaminophen—CYP2A6—liver—colon cancer	0.000501	0.00691	CbGeAlD
Acetaminophen—ABCB1—blood vessel—colon cancer	0.000489	0.00674	CbGeAlD
Acetaminophen—PTGS2—embryo—colon cancer	0.000471	0.0065	CbGeAlD
Acetaminophen—CYP2C8—renal system—colon cancer	0.00046	0.00635	CbGeAlD
Acetaminophen—CYP1A1—epithelium—colon cancer	0.000458	0.00632	CbGeAlD
Acetaminophen—CYP1A2—renal system—colon cancer	0.000431	0.00594	CbGeAlD
Acetaminophen—CYP1A1—renal system—colon cancer	0.000425	0.00586	CbGeAlD
Acetaminophen—PTGS1—epithelium—colon cancer	0.000402	0.00555	CbGeAlD
Acetaminophen—PTGS1—smooth muscle tissue—colon cancer	0.000388	0.00535	CbGeAlD
Acetaminophen—CYP2E1—renal system—colon cancer	0.000387	0.00534	CbGeAlD
Acetaminophen—PTGS2—epithelium—colon cancer	0.000385	0.0053	CbGeAlD
Acetaminophen—PTGS1—renal system—colon cancer	0.000373	0.00515	CbGeAlD
Acetaminophen—PTGS2—smooth muscle tissue—colon cancer	0.000371	0.00511	CbGeAlD
Acetaminophen—PTGS2—renal system—colon cancer	0.000357	0.00492	CbGeAlD
Acetaminophen—CYP1A2—digestive system—colon cancer	0.000353	0.00487	CbGeAlD
Acetaminophen—CYP1A1—digestive system—colon cancer	0.000348	0.0048	CbGeAlD
Acetaminophen—CYP2C9—digestive system—colon cancer	0.000335	0.00462	CbGeAlD
Acetaminophen—CYP2C8—vagina—colon cancer	0.000333	0.0046	CbGeAlD
Acetaminophen—CYP2E1—lymphoid tissue—colon cancer	0.000322	0.00444	CbGeAlD
Acetaminophen—CYP2E1—digestive system—colon cancer	0.000318	0.00438	CbGeAlD
Acetaminophen—CYP3A4—renal system—colon cancer	0.000312	0.0043	CbGeAlD
Acetaminophen—CYP1A1—vagina—colon cancer	0.000308	0.00424	CbGeAlD
Acetaminophen—CYP2D6—renal system—colon cancer	0.000307	0.00423	CbGeAlD
Acetaminophen—PTGS1—digestive system—colon cancer	0.000306	0.00422	CbGeAlD
Acetaminophen—PTGS2—lymphoid tissue—colon cancer	0.000296	0.00408	CbGeAlD
Acetaminophen—PTGS2—digestive system—colon cancer	0.000293	0.00403	CbGeAlD
Acetaminophen—ABCB1—embryo—colon cancer	0.000292	0.00402	CbGeAlD
Acetaminophen—CYP2C8—liver—colon cancer	0.000281	0.00388	CbGeAlD
Acetaminophen—Abdominal distension—Capecitabine—colon cancer	0.000279	0.00271	CcSEcCtD
Acetaminophen—Muscle spasms—Irinotecan—colon cancer	0.000277	0.00269	CcSEcCtD
Acetaminophen—Asthma—Capecitabine—colon cancer	0.000277	0.00269	CcSEcCtD
Acetaminophen—Erythema—Fluorouracil—colon cancer	0.000276	0.00268	CcSEcCtD
Acetaminophen—Anaemia—Vincristine—colon cancer	0.000274	0.00266	CcSEcCtD
Acetaminophen—Bronchospasm—Capecitabine—colon cancer	0.000273	0.00265	CcSEcCtD
Acetaminophen—Agitation—Vincristine—colon cancer	0.000272	0.00264	CcSEcCtD
Acetaminophen—Photosensitivity—Methotrexate—colon cancer	0.000272	0.00264	CcSEcCtD
Acetaminophen—PTGS1—vagina—colon cancer	0.00027	0.00373	CbGeAlD
Acetaminophen—Sweating increased—Capecitabine—colon cancer	0.00027	0.00262	CcSEcCtD
Acetaminophen—PTGS2—bone marrow—colon cancer	0.00027	0.00372	CbGeAlD
Acetaminophen—Ill-defined disorder—Irinotecan—colon cancer	0.000268	0.0026	CcSEcCtD
Acetaminophen—Anaemia—Irinotecan—colon cancer	0.000267	0.00259	CcSEcCtD
Acetaminophen—Abdominal discomfort—Capecitabine—colon cancer	0.000266	0.00258	CcSEcCtD
Acetaminophen—Hepatic failure—Methotrexate—colon cancer	0.000266	0.00258	CcSEcCtD
Acetaminophen—Leukopenia—Vincristine—colon cancer	0.000265	0.00257	CcSEcCtD
Acetaminophen—Pancytopenia—Capecitabine—colon cancer	0.000263	0.00256	CcSEcCtD
Acetaminophen—CYP1A2—liver—colon cancer	0.000263	0.00363	CbGeAlD
Acetaminophen—Vision blurred—Fluorouracil—colon cancer	0.00026	0.00253	CcSEcCtD
Acetaminophen—Malaise—Irinotecan—colon cancer	0.00026	0.00253	CcSEcCtD
Acetaminophen—CYP1A1—liver—colon cancer	0.00026	0.00358	CbGeAlD
Acetaminophen—Neutropenia—Capecitabine—colon cancer	0.000259	0.00252	CcSEcCtD
Acetaminophen—Dysuria—Capecitabine—colon cancer	0.000259	0.00252	CcSEcCtD
Acetaminophen—Renal failure acute—Methotrexate—colon cancer	0.000259	0.00251	CcSEcCtD
Acetaminophen—PTGS2—vagina—colon cancer	0.000258	0.00356	CbGeAlD
Acetaminophen—Leukopenia—Irinotecan—colon cancer	0.000258	0.00251	CcSEcCtD
Acetaminophen—Convulsion—Vincristine—colon cancer	0.000257	0.00249	CcSEcCtD
Acetaminophen—Hypertension—Vincristine—colon cancer	0.000256	0.00248	CcSEcCtD
Acetaminophen—CYP3A4—digestive system—colon cancer	0.000256	0.00353	CbGeAlD
Acetaminophen—Anaemia—Fluorouracil—colon cancer	0.000255	0.00248	CcSEcCtD
Acetaminophen—Dermatitis exfoliative—Methotrexate—colon cancer	0.000253	0.00246	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Capecitabine—colon cancer	0.000253	0.00246	CcSEcCtD
Acetaminophen—Cough—Irinotecan—colon cancer	0.000252	0.00244	CcSEcCtD
Acetaminophen—CYP2D6—digestive system—colon cancer	0.000252	0.00347	CbGeAlD
Acetaminophen—Hyperglycaemia—Capecitabine—colon cancer	0.00025	0.00243	CcSEcCtD
Acetaminophen—CYP2C9—liver—colon cancer	0.00025	0.00344	CbGeAlD
Acetaminophen—Hypertension—Irinotecan—colon cancer	0.000249	0.00242	CcSEcCtD
Acetaminophen—Leukopenia—Fluorouracil—colon cancer	0.000247	0.0024	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000245	0.00238	CcSEcCtD
Acetaminophen—Discomfort—Irinotecan—colon cancer	0.000243	0.00236	CcSEcCtD
Acetaminophen—Oedema—Vincristine—colon cancer	0.000242	0.00235	CcSEcCtD
Acetaminophen—Anaphylactic shock—Vincristine—colon cancer	0.000242	0.00235	CcSEcCtD
Acetaminophen—Convulsion—Fluorouracil—colon cancer	0.000239	0.00232	CcSEcCtD
Acetaminophen—ABCB1—epithelium—colon cancer	0.000238	0.00328	CbGeAlD
Acetaminophen—Confusional state—Irinotecan—colon cancer	0.000237	0.0023	CcSEcCtD
Acetaminophen—Nervous system disorder—Vincristine—colon cancer	0.000237	0.0023	CcSEcCtD
Acetaminophen—Thrombocytopenia—Vincristine—colon cancer	0.000237	0.0023	CcSEcCtD
Acetaminophen—CYP2E1—liver—colon cancer	0.000237	0.00326	CbGeAlD
Acetaminophen—Oedema—Irinotecan—colon cancer	0.000236	0.00229	CcSEcCtD
Acetaminophen—Anaphylactic shock—Irinotecan—colon cancer	0.000236	0.00229	CcSEcCtD
Acetaminophen—Chest pain—Fluorouracil—colon cancer	0.000235	0.00228	CcSEcCtD
Acetaminophen—Hyperhidrosis—Vincristine—colon cancer	0.000234	0.00227	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Capecitabine—colon cancer	0.000234	0.00227	CcSEcCtD
Acetaminophen—Discomfort—Fluorouracil—colon cancer	0.000232	0.00226	CcSEcCtD
Acetaminophen—Shock—Irinotecan—colon cancer	0.000232	0.00225	CcSEcCtD
Acetaminophen—Nervous system disorder—Irinotecan—colon cancer	0.000231	0.00224	CcSEcCtD
Acetaminophen—Agranulocytosis—Capecitabine—colon cancer	0.000231	0.00224	CcSEcCtD
Acetaminophen—Thrombocytopenia—Irinotecan—colon cancer	0.000231	0.00224	CcSEcCtD
Acetaminophen—Anorexia—Vincristine—colon cancer	0.000231	0.00224	CcSEcCtD
Acetaminophen—Irritability—Methotrexate—colon cancer	0.000228	0.00221	CcSEcCtD
Acetaminophen—Hyperhidrosis—Irinotecan—colon cancer	0.000228	0.00221	CcSEcCtD
Acetaminophen—Confusional state—Fluorouracil—colon cancer	0.000227	0.00221	CcSEcCtD
Acetaminophen—Hypotension—Vincristine—colon cancer	0.000226	0.00219	CcSEcCtD
Acetaminophen—Anaphylactic shock—Fluorouracil—colon cancer	0.000226	0.00219	CcSEcCtD
Acetaminophen—Oedema—Fluorouracil—colon cancer	0.000226	0.00219	CcSEcCtD
Acetaminophen—Anorexia—Irinotecan—colon cancer	0.000224	0.00218	CcSEcCtD
Acetaminophen—Haemoglobin—Capecitabine—colon cancer	0.000223	0.00216	CcSEcCtD
Acetaminophen—Haemorrhage—Capecitabine—colon cancer	0.000222	0.00215	CcSEcCtD
Acetaminophen—Hepatitis—Capecitabine—colon cancer	0.000222	0.00215	CcSEcCtD
Acetaminophen—Nervous system disorder—Fluorouracil—colon cancer	0.000221	0.00215	CcSEcCtD
Acetaminophen—Thrombocytopenia—Fluorouracil—colon cancer	0.000221	0.00214	CcSEcCtD
Acetaminophen—ABCB1—renal system—colon cancer	0.000221	0.00304	CbGeAlD
Acetaminophen—Tachycardia—Fluorouracil—colon cancer	0.00022	0.00214	CcSEcCtD
Acetaminophen—Hypotension—Irinotecan—colon cancer	0.00022	0.00214	CcSEcCtD
Acetaminophen—Urinary tract disorder—Capecitabine—colon cancer	0.000219	0.00213	CcSEcCtD
Acetaminophen—Insomnia—Vincristine—colon cancer	0.000219	0.00212	CcSEcCtD
Acetaminophen—Oedema peripheral—Capecitabine—colon cancer	0.000219	0.00212	CcSEcCtD
Acetaminophen—Connective tissue disorder—Capecitabine—colon cancer	0.000218	0.00212	CcSEcCtD
Acetaminophen—PTGS2—liver—colon cancer	0.000218	0.00301	CbGeAlD
Acetaminophen—Urethral disorder—Capecitabine—colon cancer	0.000217	0.00211	CcSEcCtD
Acetaminophen—Anorexia—Fluorouracil—colon cancer	0.000215	0.00209	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000215	0.00209	CcSEcCtD
Acetaminophen—Insomnia—Irinotecan—colon cancer	0.000213	0.00207	CcSEcCtD
Acetaminophen—Hypotension—Fluorouracil—colon cancer	0.000211	0.00205	CcSEcCtD
Acetaminophen—Decreased appetite—Vincristine—colon cancer	0.00021	0.00204	CcSEcCtD
Acetaminophen—Dyspnoea—Irinotecan—colon cancer	0.00021	0.00204	CcSEcCtD
Acetaminophen—Erythema multiforme—Capecitabine—colon cancer	0.00021	0.00204	CcSEcCtD
Acetaminophen—Somnolence—Irinotecan—colon cancer	0.000209	0.00203	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Vincristine—colon cancer	0.000209	0.00203	CcSEcCtD
Acetaminophen—Fatigue—Vincristine—colon cancer	0.000209	0.00202	CcSEcCtD
Acetaminophen—Eye disorder—Capecitabine—colon cancer	0.000207	0.00201	CcSEcCtD
Acetaminophen—Dyspepsia—Irinotecan—colon cancer	0.000207	0.00201	CcSEcCtD
Acetaminophen—Constipation—Vincristine—colon cancer	0.000207	0.00201	CcSEcCtD
Acetaminophen—Asthma—Methotrexate—colon cancer	0.000206	0.002	CcSEcCtD
Acetaminophen—Flushing—Capecitabine—colon cancer	0.000206	0.002	CcSEcCtD
Acetaminophen—Cardiac disorder—Capecitabine—colon cancer	0.000206	0.002	CcSEcCtD
Acetaminophen—Decreased appetite—Irinotecan—colon cancer	0.000205	0.00199	CcSEcCtD
Acetaminophen—Insomnia—Fluorouracil—colon cancer	0.000204	0.00198	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Irinotecan—colon cancer	0.000203	0.00197	CcSEcCtD
Acetaminophen—Fatigue—Irinotecan—colon cancer	0.000203	0.00197	CcSEcCtD
Acetaminophen—Constipation—Irinotecan—colon cancer	0.000201	0.00195	CcSEcCtD
Acetaminophen—Angiopathy—Capecitabine—colon cancer	0.000201	0.00195	CcSEcCtD
Acetaminophen—Dyspnoea—Fluorouracil—colon cancer	0.000201	0.00195	CcSEcCtD
Acetaminophen—Somnolence—Fluorouracil—colon cancer	0.000201	0.00195	CcSEcCtD
Acetaminophen—Immune system disorder—Capecitabine—colon cancer	0.0002	0.00195	CcSEcCtD
Acetaminophen—Mediastinal disorder—Capecitabine—colon cancer	0.0002	0.00194	CcSEcCtD
Acetaminophen—Chills—Capecitabine—colon cancer	0.000199	0.00193	CcSEcCtD
Acetaminophen—CYP1A1—lymph node—colon cancer	0.000199	0.00274	CbGeAlD
Acetaminophen—Dyspepsia—Fluorouracil—colon cancer	0.000199	0.00193	CcSEcCtD
Acetaminophen—Abdominal discomfort—Methotrexate—colon cancer	0.000198	0.00192	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Vincristine—colon cancer	0.000198	0.00192	CcSEcCtD
Acetaminophen—Decreased appetite—Fluorouracil—colon cancer	0.000196	0.0019	CcSEcCtD
Acetaminophen—Pancytopenia—Methotrexate—colon cancer	0.000196	0.0019	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000195	0.00189	CcSEcCtD
Acetaminophen—Mental disorder—Capecitabine—colon cancer	0.000194	0.00189	CcSEcCtD
Acetaminophen—Feeling abnormal—Irinotecan—colon cancer	0.000194	0.00188	CcSEcCtD
Acetaminophen—Malnutrition—Capecitabine—colon cancer	0.000193	0.00187	CcSEcCtD
Acetaminophen—Erythema—Capecitabine—colon cancer	0.000193	0.00187	CcSEcCtD
Acetaminophen—Dysuria—Methotrexate—colon cancer	0.000193	0.00187	CcSEcCtD
Acetaminophen—Neutropenia—Methotrexate—colon cancer	0.000193	0.00187	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Irinotecan—colon cancer	0.000193	0.00187	CcSEcCtD
Acetaminophen—Abdominal pain—Vincristine—colon cancer	0.000191	0.00186	CcSEcCtD
Acetaminophen—Body temperature increased—Vincristine—colon cancer	0.000191	0.00186	CcSEcCtD
Acetaminophen—CYP3A4—liver—colon cancer	0.00019	0.00263	CbGeAlD
Acetaminophen—Photosensitivity reaction—Methotrexate—colon cancer	0.000188	0.00183	CcSEcCtD
Acetaminophen—CYP2D6—liver—colon cancer	0.000187	0.00258	CbGeAlD
Acetaminophen—Abdominal pain—Irinotecan—colon cancer	0.000186	0.00181	CcSEcCtD
Acetaminophen—Body temperature increased—Irinotecan—colon cancer	0.000186	0.00181	CcSEcCtD
Acetaminophen—Feeling abnormal—Fluorouracil—colon cancer	0.000186	0.0018	CcSEcCtD
Acetaminophen—Muscle spasms—Capecitabine—colon cancer	0.000186	0.0018	CcSEcCtD
Acetaminophen—Drowsiness—Methotrexate—colon cancer	0.000184	0.00179	CcSEcCtD
Acetaminophen—ABCB1—lymphoid tissue—colon cancer	0.000183	0.00253	CbGeAlD
Acetaminophen—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000182	0.00177	CcSEcCtD
Acetaminophen—Vision blurred—Capecitabine—colon cancer	0.000182	0.00177	CcSEcCtD
Acetaminophen—ABCB1—digestive system—colon cancer	0.000181	0.0025	CbGeAlD
Acetaminophen—Tremor—Capecitabine—colon cancer	0.000181	0.00176	CcSEcCtD
Acetaminophen—Ill-defined disorder—Capecitabine—colon cancer	0.000179	0.00174	CcSEcCtD
Acetaminophen—Urticaria—Fluorouracil—colon cancer	0.000179	0.00174	CcSEcCtD
Acetaminophen—Anaemia—Capecitabine—colon cancer	0.000179	0.00173	CcSEcCtD
Acetaminophen—Body temperature increased—Fluorouracil—colon cancer	0.000178	0.00173	CcSEcCtD
Acetaminophen—Hypersensitivity—Vincristine—colon cancer	0.000178	0.00173	CcSEcCtD
Acetaminophen—Sweating—Methotrexate—colon cancer	0.000176	0.00171	CcSEcCtD
Acetaminophen—PTGS1—lymph node—colon cancer	0.000175	0.00241	CbGeAlD
Acetaminophen—Malaise—Capecitabine—colon cancer	0.000174	0.00169	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Methotrexate—colon cancer	0.000174	0.00169	CcSEcCtD
Acetaminophen—Hypersensitivity—Irinotecan—colon cancer	0.000174	0.00168	CcSEcCtD
Acetaminophen—Asthenia—Vincristine—colon cancer	0.000174	0.00168	CcSEcCtD
Acetaminophen—Leukopenia—Capecitabine—colon cancer	0.000173	0.00168	CcSEcCtD
Acetaminophen—Agranulocytosis—Methotrexate—colon cancer	0.000172	0.00167	CcSEcCtD
Acetaminophen—Palpitations—Capecitabine—colon cancer	0.000171	0.00166	CcSEcCtD
Acetaminophen—Asthenia—Irinotecan—colon cancer	0.000169	0.00164	CcSEcCtD
Acetaminophen—Cough—Capecitabine—colon cancer	0.000169	0.00164	CcSEcCtD
Acetaminophen—PTGS2—lymph node—colon cancer	0.000167	0.0023	CbGeAlD
Acetaminophen—ABCB1—bone marrow—colon cancer	0.000167	0.0023	CbGeAlD
Acetaminophen—Hypertension—Capecitabine—colon cancer	0.000167	0.00162	CcSEcCtD
Acetaminophen—Hypersensitivity—Fluorouracil—colon cancer	0.000166	0.00161	CcSEcCtD
Acetaminophen—Haemoglobin—Methotrexate—colon cancer	0.000166	0.00161	CcSEcCtD
Acetaminophen—Diarrhoea—Vincristine—colon cancer	0.000165	0.00161	CcSEcCtD
Acetaminophen—Hepatitis—Methotrexate—colon cancer	0.000165	0.0016	CcSEcCtD
Acetaminophen—Haemorrhage—Methotrexate—colon cancer	0.000165	0.0016	CcSEcCtD
Acetaminophen—Chest pain—Capecitabine—colon cancer	0.000164	0.0016	CcSEcCtD
Acetaminophen—Anxiety—Capecitabine—colon cancer	0.000164	0.00159	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000163	0.00159	CcSEcCtD
Acetaminophen—Urinary tract disorder—Methotrexate—colon cancer	0.000163	0.00158	CcSEcCtD
Acetaminophen—Discomfort—Capecitabine—colon cancer	0.000162	0.00158	CcSEcCtD
Acetaminophen—Urethral disorder—Methotrexate—colon cancer	0.000162	0.00157	CcSEcCtD
Acetaminophen—Diarrhoea—Irinotecan—colon cancer	0.000161	0.00156	CcSEcCtD
Acetaminophen—Dry mouth—Capecitabine—colon cancer	0.000161	0.00156	CcSEcCtD
Acetaminophen—Dizziness—Vincristine—colon cancer	0.00016	0.00155	CcSEcCtD
Acetaminophen—ABCB1—vagina—colon cancer	0.00016	0.0022	CbGeAlD
Acetaminophen—Pruritus—Fluorouracil—colon cancer	0.00016	0.00155	CcSEcCtD
Acetaminophen—Confusional state—Capecitabine—colon cancer	0.000159	0.00154	CcSEcCtD
Acetaminophen—Oedema—Capecitabine—colon cancer	0.000158	0.00153	CcSEcCtD
Acetaminophen—Erythema multiforme—Methotrexate—colon cancer	0.000156	0.00152	CcSEcCtD
Acetaminophen—Dizziness—Irinotecan—colon cancer	0.000156	0.00151	CcSEcCtD
Acetaminophen—Shock—Capecitabine—colon cancer	0.000155	0.00151	CcSEcCtD
Acetaminophen—Nervous system disorder—Capecitabine—colon cancer	0.000155	0.0015	CcSEcCtD
Acetaminophen—Eye disorder—Methotrexate—colon cancer	0.000154	0.0015	CcSEcCtD
Acetaminophen—Diarrhoea—Fluorouracil—colon cancer	0.000154	0.0015	CcSEcCtD
Acetaminophen—Thrombocytopenia—Capecitabine—colon cancer	0.000154	0.0015	CcSEcCtD
Acetaminophen—Tachycardia—Capecitabine—colon cancer	0.000154	0.00149	CcSEcCtD
Acetaminophen—Vomiting—Vincristine—colon cancer	0.000154	0.00149	CcSEcCtD
Acetaminophen—Cardiac disorder—Methotrexate—colon cancer	0.000153	0.00149	CcSEcCtD
Acetaminophen—Skin disorder—Capecitabine—colon cancer	0.000153	0.00149	CcSEcCtD
Acetaminophen—Rash—Vincristine—colon cancer	0.000152	0.00148	CcSEcCtD
Acetaminophen—Hyperhidrosis—Capecitabine—colon cancer	0.000152	0.00148	CcSEcCtD
Acetaminophen—Dermatitis—Vincristine—colon cancer	0.000152	0.00148	CcSEcCtD
Acetaminophen—Headache—Vincristine—colon cancer	0.000152	0.00147	CcSEcCtD
Acetaminophen—Anorexia—Capecitabine—colon cancer	0.00015	0.00146	CcSEcCtD
Acetaminophen—Angiopathy—Methotrexate—colon cancer	0.00015	0.00145	CcSEcCtD
Acetaminophen—Vomiting—Irinotecan—colon cancer	0.00015	0.00145	CcSEcCtD
Acetaminophen—Immune system disorder—Methotrexate—colon cancer	0.000149	0.00145	CcSEcCtD
Acetaminophen—Dizziness—Fluorouracil—colon cancer	0.000149	0.00145	CcSEcCtD
Acetaminophen—Mediastinal disorder—Methotrexate—colon cancer	0.000149	0.00144	CcSEcCtD
Acetaminophen—Rash—Irinotecan—colon cancer	0.000148	0.00144	CcSEcCtD
Acetaminophen—Dermatitis—Irinotecan—colon cancer	0.000148	0.00144	CcSEcCtD
Acetaminophen—Chills—Methotrexate—colon cancer	0.000148	0.00144	CcSEcCtD
Acetaminophen—Headache—Irinotecan—colon cancer	0.000148	0.00143	CcSEcCtD
Acetaminophen—Hypotension—Capecitabine—colon cancer	0.000147	0.00143	CcSEcCtD
Acetaminophen—Mental disorder—Methotrexate—colon cancer	0.000145	0.0014	CcSEcCtD
Acetaminophen—Erythema—Methotrexate—colon cancer	0.000144	0.0014	CcSEcCtD
Acetaminophen—Malnutrition—Methotrexate—colon cancer	0.000144	0.0014	CcSEcCtD
Acetaminophen—Nausea—Vincristine—colon cancer	0.000144	0.00139	CcSEcCtD
Acetaminophen—Vomiting—Fluorouracil—colon cancer	0.000143	0.00139	CcSEcCtD
Acetaminophen—Insomnia—Capecitabine—colon cancer	0.000143	0.00138	CcSEcCtD
Acetaminophen—Rash—Fluorouracil—colon cancer	0.000142	0.00138	CcSEcCtD
Acetaminophen—Dermatitis—Fluorouracil—colon cancer	0.000142	0.00138	CcSEcCtD
Acetaminophen—Headache—Fluorouracil—colon cancer	0.000141	0.00137	CcSEcCtD
Acetaminophen—Dyspnoea—Capecitabine—colon cancer	0.000141	0.00136	CcSEcCtD
Acetaminophen—Nausea—Irinotecan—colon cancer	0.00014	0.00136	CcSEcCtD
Acetaminophen—Dyspepsia—Capecitabine—colon cancer	0.000139	0.00135	CcSEcCtD
Acetaminophen—Decreased appetite—Capecitabine—colon cancer	0.000137	0.00133	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Capecitabine—colon cancer	0.000136	0.00132	CcSEcCtD
Acetaminophen—Fatigue—Capecitabine—colon cancer	0.000136	0.00132	CcSEcCtD
Acetaminophen—Vision blurred—Methotrexate—colon cancer	0.000136	0.00132	CcSEcCtD
Acetaminophen—ABCB1—liver—colon cancer	0.000135	0.00186	CbGeAlD
Acetaminophen—Constipation—Capecitabine—colon cancer	0.000135	0.00131	CcSEcCtD
Acetaminophen—Nausea—Fluorouracil—colon cancer	0.000134	0.0013	CcSEcCtD
Acetaminophen—Ill-defined disorder—Methotrexate—colon cancer	0.000133	0.00129	CcSEcCtD
Acetaminophen—Anaemia—Methotrexate—colon cancer	0.000133	0.00129	CcSEcCtD
Acetaminophen—Feeling abnormal—Capecitabine—colon cancer	0.00013	0.00126	CcSEcCtD
Acetaminophen—Malaise—Methotrexate—colon cancer	0.00013	0.00126	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Capecitabine—colon cancer	0.000129	0.00125	CcSEcCtD
Acetaminophen—Leukopenia—Methotrexate—colon cancer	0.000129	0.00125	CcSEcCtD
Acetaminophen—Cough—Methotrexate—colon cancer	0.000125	0.00122	CcSEcCtD
Acetaminophen—Urticaria—Capecitabine—colon cancer	0.000125	0.00122	CcSEcCtD
Acetaminophen—Abdominal pain—Capecitabine—colon cancer	0.000125	0.00121	CcSEcCtD
Acetaminophen—Body temperature increased—Capecitabine—colon cancer	0.000125	0.00121	CcSEcCtD
Acetaminophen—Convulsion—Methotrexate—colon cancer	0.000125	0.00121	CcSEcCtD
Acetaminophen—Chest pain—Methotrexate—colon cancer	0.000122	0.00119	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000122	0.00118	CcSEcCtD
Acetaminophen—Discomfort—Methotrexate—colon cancer	0.000121	0.00117	CcSEcCtD
Acetaminophen—Confusional state—Methotrexate—colon cancer	0.000118	0.00115	CcSEcCtD
Acetaminophen—Anaphylactic shock—Methotrexate—colon cancer	0.000117	0.00114	CcSEcCtD
Acetaminophen—Hypersensitivity—Capecitabine—colon cancer	0.000116	0.00113	CcSEcCtD
Acetaminophen—Nervous system disorder—Methotrexate—colon cancer	0.000115	0.00112	CcSEcCtD
Acetaminophen—Thrombocytopenia—Methotrexate—colon cancer	0.000115	0.00112	CcSEcCtD
Acetaminophen—Skin disorder—Methotrexate—colon cancer	0.000114	0.00111	CcSEcCtD
Acetaminophen—Hyperhidrosis—Methotrexate—colon cancer	0.000113	0.0011	CcSEcCtD
Acetaminophen—Asthenia—Capecitabine—colon cancer	0.000113	0.0011	CcSEcCtD
Acetaminophen—Anorexia—Methotrexate—colon cancer	0.000112	0.00109	CcSEcCtD
Acetaminophen—Pruritus—Capecitabine—colon cancer	0.000112	0.00108	CcSEcCtD
Acetaminophen—Hypotension—Methotrexate—colon cancer	0.00011	0.00106	CcSEcCtD
Acetaminophen—Diarrhoea—Capecitabine—colon cancer	0.000108	0.00105	CcSEcCtD
Acetaminophen—Insomnia—Methotrexate—colon cancer	0.000106	0.00103	CcSEcCtD
Acetaminophen—Dyspnoea—Methotrexate—colon cancer	0.000105	0.00102	CcSEcCtD
Acetaminophen—Somnolence—Methotrexate—colon cancer	0.000104	0.00101	CcSEcCtD
Acetaminophen—Dizziness—Capecitabine—colon cancer	0.000104	0.00101	CcSEcCtD
Acetaminophen—ABCB1—lymph node—colon cancer	0.000103	0.00143	CbGeAlD
Acetaminophen—Dyspepsia—Methotrexate—colon cancer	0.000103	0.001	CcSEcCtD
Acetaminophen—Decreased appetite—Methotrexate—colon cancer	0.000102	0.00099	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Methotrexate—colon cancer	0.000101	0.000983	CcSEcCtD
Acetaminophen—Fatigue—Methotrexate—colon cancer	0.000101	0.000982	CcSEcCtD
Acetaminophen—Vomiting—Capecitabine—colon cancer	0.0001	0.000973	CcSEcCtD
Acetaminophen—Rash—Capecitabine—colon cancer	9.94e-05	0.000965	CcSEcCtD
Acetaminophen—Dermatitis—Capecitabine—colon cancer	9.93e-05	0.000964	CcSEcCtD
Acetaminophen—Headache—Capecitabine—colon cancer	9.87e-05	0.000958	CcSEcCtD
Acetaminophen—Feeling abnormal—Methotrexate—colon cancer	9.67e-05	0.000939	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Methotrexate—colon cancer	9.6e-05	0.000931	CcSEcCtD
Acetaminophen—Nausea—Capecitabine—colon cancer	9.36e-05	0.000909	CcSEcCtD
Acetaminophen—Urticaria—Methotrexate—colon cancer	9.32e-05	0.000905	CcSEcCtD
Acetaminophen—Abdominal pain—Methotrexate—colon cancer	9.28e-05	0.0009	CcSEcCtD
Acetaminophen—Body temperature increased—Methotrexate—colon cancer	9.28e-05	0.0009	CcSEcCtD
Acetaminophen—Hypersensitivity—Methotrexate—colon cancer	8.65e-05	0.000839	CcSEcCtD
Acetaminophen—Asthenia—Methotrexate—colon cancer	8.42e-05	0.000817	CcSEcCtD
Acetaminophen—Pruritus—Methotrexate—colon cancer	8.3e-05	0.000806	CcSEcCtD
Acetaminophen—Diarrhoea—Methotrexate—colon cancer	8.03e-05	0.000779	CcSEcCtD
Acetaminophen—Dizziness—Methotrexate—colon cancer	7.76e-05	0.000753	CcSEcCtD
Acetaminophen—Vomiting—Methotrexate—colon cancer	7.46e-05	0.000724	CcSEcCtD
Acetaminophen—Rash—Methotrexate—colon cancer	7.4e-05	0.000718	CcSEcCtD
Acetaminophen—Dermatitis—Methotrexate—colon cancer	7.39e-05	0.000717	CcSEcCtD
Acetaminophen—Headache—Methotrexate—colon cancer	7.35e-05	0.000714	CcSEcCtD
Acetaminophen—Nausea—Methotrexate—colon cancer	6.97e-05	0.000677	CcSEcCtD
Acetaminophen—UGT1A6—Metabolism—ABCB1—colon cancer	3.55e-05	0.000504	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	3.55e-05	0.000504	CbGpPWpGaD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	3.55e-05	0.000504	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—TYMS—colon cancer	3.49e-05	0.000495	CbGpPWpGaD
Acetaminophen—CYP1A1—PPARA activates gene expression—EP300—colon cancer	3.44e-05	0.000489	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PTGS2—colon cancer	3.42e-05	0.000486	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ODC1—colon cancer	3.42e-05	0.000486	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CHST5—colon cancer	3.42e-05	0.000486	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—VEGFA—colon cancer	3.39e-05	0.000482	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	3.39e-05	0.000481	CbGpPWpGaD
Acetaminophen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	3.37e-05	0.000478	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—AXIN2—colon cancer	3.31e-05	0.00047	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PPARG—colon cancer	3.3e-05	0.000469	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	3.29e-05	0.000468	CbGpPWpGaD
Acetaminophen—CYP2A6—NRF2 pathway—TGFB1—colon cancer	3.2e-05	0.000455	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—MYC—colon cancer	3.19e-05	0.000454	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	3.19e-05	0.000453	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PPARG—colon cancer	3.15e-05	0.000447	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ODC1—colon cancer	3.14e-05	0.000445	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CHST5—colon cancer	3.14e-05	0.000445	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—EGFR—colon cancer	3.12e-05	0.000444	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—TGFB1—colon cancer	3.11e-05	0.000442	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	3.02e-05	0.000428	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PTGS2—colon cancer	3.01e-05	0.000428	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PPARG—colon cancer	2.96e-05	0.00042	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—EP300—colon cancer	2.85e-05	0.000405	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.8e-05	0.000398	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.78e-05	0.000395	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CA7—colon cancer	2.78e-05	0.000395	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—FGFR3—colon cancer	2.74e-05	0.000389	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ODC1—colon cancer	2.73e-05	0.000388	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CHST5—colon cancer	2.73e-05	0.000388	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.71e-05	0.000385	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.68e-05	0.000381	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TP53—colon cancer	2.62e-05	0.000373	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.62e-05	0.000372	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PTGS2—colon cancer	2.6e-05	0.000369	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ODC1—colon cancer	2.58e-05	0.000366	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CHST5—colon cancer	2.58e-05	0.000366	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CHST5—colon cancer	2.55e-05	0.000363	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ODC1—colon cancer	2.55e-05	0.000363	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—APC—colon cancer	2.52e-05	0.000357	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—NRAS—colon cancer	2.52e-05	0.000357	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—EP300—colon cancer	2.51e-05	0.000356	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.5e-05	0.000355	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.49e-05	0.000354	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PTGS2—colon cancer	2.48e-05	0.000352	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PPARG—colon cancer	2.47e-05	0.000351	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.46e-05	0.000349	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.42e-05	0.000344	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—BRAF—colon cancer	2.37e-05	0.000336	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.36e-05	0.000335	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PTGS2—colon cancer	2.33e-05	0.000331	CbGpPWpGaD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	2.32e-05	0.00033	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—EGFR—colon cancer	2.29e-05	0.000326	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—PIK3CA—colon cancer	2.19e-05	0.000311	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CHST5—colon cancer	2.18e-05	0.00031	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ODC1—colon cancer	2.18e-05	0.00031	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.17e-05	0.000309	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.17e-05	0.000308	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—KRAS—colon cancer	2.17e-05	0.000308	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—EP300—colon cancer	2.16e-05	0.000307	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.13e-05	0.000302	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.13e-05	0.000302	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PIK3CA—colon cancer	2.11e-05	0.000299	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—EP300—colon cancer	2.06e-05	0.000292	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.01e-05	0.000285	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2e-05	0.000285	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—PIK3CA—colon cancer	1.99e-05	0.000283	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.97e-05	0.00028	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PTGS2—colon cancer	1.94e-05	0.000276	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—EP300—colon cancer	1.94e-05	0.000275	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.93e-05	0.000275	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.92e-05	0.000273	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.9e-05	0.00027	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.86e-05	0.000264	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PIK3CA—colon cancer	1.85e-05	0.000263	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.84e-05	0.000262	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—HRAS—colon cancer	1.84e-05	0.000261	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—AKT1—colon cancer	1.79e-05	0.000254	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.78e-05	0.000253	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CASP3—colon cancer	1.77e-05	0.000252	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.77e-05	0.000251	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCND1—colon cancer	1.73e-05	0.000245	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—AKT1—colon cancer	1.72e-05	0.000244	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.72e-05	0.000244	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CTNNB1—colon cancer	1.71e-05	0.000243	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ODC1—colon cancer	1.68e-05	0.000239	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CHST5—colon cancer	1.68e-05	0.000239	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.67e-05	0.000238	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CDKN1A—colon cancer	1.67e-05	0.000237	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—AKT1—colon cancer	1.63e-05	0.000231	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—EP300—colon cancer	1.62e-05	0.000229	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.61e-05	0.000229	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PIK3CA—colon cancer	1.6e-05	0.000227	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.59e-05	0.000226	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—EP300—colon cancer	1.59e-05	0.000226	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.58e-05	0.000224	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ABCB1—colon cancer	1.57e-05	0.000224	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ABCB1—colon cancer	1.57e-05	0.000224	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—TYMS—colon cancer	1.55e-05	0.00022	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—TYMS—colon cancer	1.55e-05	0.00022	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SRC—colon cancer	1.55e-05	0.000219	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.54e-05	0.000219	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.54e-05	0.000218	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PIK3CA—colon cancer	1.52e-05	0.000216	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—AKT1—colon cancer	1.52e-05	0.000215	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.51e-05	0.000214	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.51e-05	0.000214	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—VEGFA—colon cancer	1.5e-05	0.000214	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—NRAS—colon cancer	1.49e-05	0.000211	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PIK3CA—colon cancer	1.43e-05	0.000203	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.42e-05	0.000202	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.41e-05	0.000201	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MYC—colon cancer	1.38e-05	0.000197	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TGFB1—colon cancer	1.38e-05	0.000196	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—EGFR—colon cancer	1.35e-05	0.000192	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.31e-05	0.000186	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.31e-05	0.000186	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—AKT1—colon cancer	1.3e-05	0.000185	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.29e-05	0.000184	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ABCB1—colon cancer	1.28e-05	0.000182	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KRAS—colon cancer	1.28e-05	0.000182	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.26e-05	0.00018	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—TYMS—colon cancer	1.26e-05	0.000179	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—AKT1—colon cancer	1.24e-05	0.000177	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ABCB1—colon cancer	1.21e-05	0.000172	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PIK3CA—colon cancer	1.2e-05	0.00017	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—TYMS—colon cancer	1.19e-05	0.000169	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.19e-05	0.000169	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PIK3CA—colon cancer	1.18e-05	0.000167	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—AKT1—colon cancer	1.17e-05	0.000166	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—colon cancer	1.14e-05	0.000161	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.11e-05	0.000158	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PPARG—colon cancer	1.1e-05	0.000156	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PPARG—colon cancer	1.1e-05	0.000156	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—HRAS—colon cancer	1.09e-05	0.000154	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.07e-05	0.000152	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.05e-05	0.00015	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.04e-05	0.000148	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ABCB1—colon cancer	1.02e-05	0.000145	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.02e-05	0.000145	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—TYMS—colon cancer	1e-05	0.000142	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AKT1—colon cancer	9.76e-06	0.000139	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.7e-06	0.000138	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—AKT1—colon cancer	9.6e-06	0.000136	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ABCB1—colon cancer	9.59e-06	0.000136	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FGFR3—colon cancer	9.55e-06	0.000136	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—TYMS—colon cancer	9.42e-06	0.000134	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.24e-06	0.000131	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ABCB1—colon cancer	9.04e-06	0.000128	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.01e-06	0.000128	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PPARG—colon cancer	8.93e-06	0.000127	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—TYMS—colon cancer	8.88e-06	0.000126	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—APC—colon cancer	8.77e-06	0.000125	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—colon cancer	8.62e-06	0.000122	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—colon cancer	8.62e-06	0.000122	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.47e-06	0.00012	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PPARG—colon cancer	8.44e-06	0.00012	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.29e-06	0.000118	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ABCB1—colon cancer	8.29e-06	0.000118	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—BRAF—colon cancer	8.24e-06	0.000117	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—TYMS—colon cancer	8.14e-06	0.000116	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.7e-06	0.000109	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—EP300—colon cancer	7.17e-06	0.000102	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—EP300—colon cancer	7.17e-06	0.000102	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—TYMS—colon cancer	7.09e-06	0.000101	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PPARG—colon cancer	7.09e-06	0.000101	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.08e-06	0.000101	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—colon cancer	7.02e-06	9.97e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.89e-06	9.79e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.84e-06	9.71e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ABCB1—colon cancer	6.8e-06	9.66e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ABCB1—colon cancer	6.75e-06	9.58e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—TYMS—colon cancer	6.68e-06	9.49e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PPARG—colon cancer	6.67e-06	9.48e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—colon cancer	6.64e-06	9.43e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—TYMS—colon cancer	6.63e-06	9.41e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PPARG—colon cancer	6.29e-06	8.93e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.27e-06	8.9e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CTNNB1—colon cancer	5.96e-06	8.46e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.89e-06	8.37e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—EP300—colon cancer	5.84e-06	8.3e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDKN1A—colon cancer	5.82e-06	8.26e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PPARG—colon cancer	5.77e-06	8.19e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ABCB1—colon cancer	5.76e-06	8.19e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—TYMS—colon cancer	5.66e-06	8.04e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EP300—colon cancer	5.54e-06	7.86e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—EP300—colon cancer	5.52e-06	7.84e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—SRC—colon cancer	5.38e-06	7.65e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CA—colon cancer	5.3e-06	7.53e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CA—colon cancer	5.3e-06	7.53e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—colon cancer	5.25e-06	7.45e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NRAS—colon cancer	5.18e-06	7.36e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.1e-06	7.24e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PPARG—colon cancer	5.02e-06	7.14e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—colon cancer	4.95e-06	7.03e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MYC—colon cancer	4.82e-06	6.85e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TGFB1—colon cancer	4.81e-06	6.84e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PPARG—colon cancer	4.73e-06	6.72e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EGFR—colon cancer	4.72e-06	6.7e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PPARG—colon cancer	4.69e-06	6.67e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—EP300—colon cancer	4.64e-06	6.59e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—colon cancer	4.54e-06	6.44e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—colon cancer	4.46e-06	6.33e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ABCB1—colon cancer	4.45e-06	6.32e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—TYMS—colon cancer	4.37e-06	6.21e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—EP300—colon cancer	4.36e-06	6.2e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.36e-06	6.19e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AKT1—colon cancer	4.33e-06	6.15e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AKT1—colon cancer	4.33e-06	6.15e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CA—colon cancer	4.32e-06	6.14e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—EP300—colon cancer	4.12e-06	5.84e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CA—colon cancer	4.1e-06	5.82e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CA—colon cancer	4.09e-06	5.8e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPARG—colon cancer	4.01e-06	5.7e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—colon cancer	3.95e-06	5.61e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HRAS—colon cancer	3.79e-06	5.38e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—EP300—colon cancer	3.77e-06	5.36e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—colon cancer	3.72e-06	5.29e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—colon cancer	3.69e-06	5.24e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AKT1—colon cancer	3.53e-06	5.01e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CA—colon cancer	3.43e-06	4.87e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—AKT1—colon cancer	3.35e-06	4.75e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AKT1—colon cancer	3.34e-06	4.74e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—EP300—colon cancer	3.29e-06	4.67e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CA—colon cancer	3.23e-06	4.59e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—colon cancer	3.15e-06	4.48e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—EP300—colon cancer	3.1e-06	4.4e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPARG—colon cancer	3.1e-06	4.4e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—EP300—colon cancer	3.07e-06	4.36e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CA—colon cancer	3.04e-06	4.32e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AKT1—colon cancer	2.8e-06	3.98e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CA—colon cancer	2.79e-06	3.96e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AKT1—colon cancer	2.64e-06	3.75e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—EP300—colon cancer	2.62e-06	3.73e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AKT1—colon cancer	2.49e-06	3.53e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—colon cancer	2.43e-06	3.46e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CA—colon cancer	2.43e-06	3.45e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CA—colon cancer	2.29e-06	3.25e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AKT1—colon cancer	2.28e-06	3.24e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CA—colon cancer	2.27e-06	3.23e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—EP300—colon cancer	2.03e-06	2.88e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AKT1—colon cancer	1.99e-06	2.82e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CA—colon cancer	1.94e-06	2.76e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AKT1—colon cancer	1.87e-06	2.66e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AKT1—colon cancer	1.86e-06	2.64e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AKT1—colon cancer	1.59e-06	2.25e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CA—colon cancer	1.5e-06	2.13e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AKT1—colon cancer	1.22e-06	1.74e-05	CbGpPWpGaD
